Sergii V. Golovko

Sergii V. Golovko

Auto-generated profile, based on publicly available information

Sergii V. Golovko

Bogomolets National Medical University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2023 in Health of Man
Verified
Journal Article
Open access
PDF file
ONOleg Nikitin
Oleg Nikitin
SPSergii Pasіechnikov
Sergii Pasіechnikov
SGSergiy Golovko
Sergiy Golovko
IKIllia Kordubailo
Illia Kordubailo
ONOlha Nishkumay
Olha Nishkumay
The objective: to determine the bone mineral density (BMD), bone tissue quality index (TBS) and to analyze the salt transport in patients with and without urolithiasis. Materials and methods. For qualitatively assess of crystalluria, a study of salt transport was conducted. Evaluation of the structural and functional state of bone tissue was performed on the basis of the Ukrainian Osteoporosis Center of the State University “Institute of Gerontology named after D. F. Chebotareva of National Academy of Sciences of Ukraine” by X-ray absorptiometry of the “Hologic Discovery” apparatus. 80 persons (15 men and 65 women) were included in the study, the average age of the patients was 58 years. Study participants were divided into two groups depending on the presence of urolithiasis. I group (n=32) included patients without urolithiasis with somatic diseases in the remission stage, who had no signs of exclusion criteria. Osteoporosis was diagnosed in 9 (28.1%) women of this group. Patients with urolithiasis were included in the II group (n=48). Osteoporosis was diagnosed in 18 (37.5%) women and 3 (6.25%) men in this group. Results. It was established that 21 (26.2%) patients had BMD within the normal range, 29 (36.3%) patients had BMD abnormalities within the limits of osteopenia, and 30 (37.6%) patients had osteoporosis, namely: 27 (33.8%) women and 3 (3.8%) men. Analysis of BMD status demonstrated that normal densitometric values were comparable in both groups (31.2% without urolithiasis and 22.9% patients with nephrolithiasis; p>0.05). The incidence of osteopenia in patients with urolithiasis (33.3%) and without urolithiasis (40.7%) and the number of cases of detected osteoporosis also did not significantly differ (43.8% and 28.1%, respectively; p>0.05). During X-ray absorptiometry it was found that the TBS bone quality index was significantly lower in patients with urolithiasis (p<0.05). A comparative analysis of salt transport demonstrated that blood uric acid levels in patients with urolithiasis were significantly higher (p=0.02) than those in patients without nephrolithiasis. Conclusions. The results of the study indicate the need for ultrasound examination of the kidneys and salt transport when checking BMD in patients at risk of osteoporosis for early diagnosis of nephrolithiasis and correction of crystalluria. Since a decrease in TBS even with a normal BMD is also an increased risk factor for bone fractures, its timely identification and correction are extremely important in patients with nephrolithiasis. The obtained data indicate the need to conduct a correlational analysis of risk factors in the group of patients with nephrolithiasis, in particular, the influence of the state of the bone system, the TBS indicator and crystalluria.

4 August 2021 in Urologiya
Verified
Journal Article
Closed access
PDF file
SGS.V. Golovko
S.V. Golovko
AGA.S. Golovko
A.S. Golovko
The potential oncological benefit of modern technological, laboratorial and imaging studies significantly improved disease-free survival rates in patients suffering from prostate cancer (PCa). Systematic reviews carried out in men with metastatic prostate cancer (mPCa) identify plenty of studies, especially dedicated to local treatment options. Unfortunately, young and fit patients with mPCa at diagnosis present unexpected resistance towards proposed treatment. Oncological outcomes demonstrate high rate of cancer-specific and overall mortality with precursory invasion of adjacent structures and impaired quality of life in patients. Current literature review was carried out using mainly PubMed and SciELO database to identify and analyze advances of local treatment of mPCa. The most relevant articles included studies performed from March 2005 to November 2020. According to the last brief reviews, main indication for providing primary treatment of PCa includes nonmetastatic PCa. Additionaly, it may be performed as palliative treatment for mPCa to minimize local invasion, prevent arising of new metastasis and provide better biological answer of chemotherapy and hormonal treatment. Recent data suggests that local treatment and overall survival turned out to be more effective in patients under 70 years. Thus, independent negative prognostic factors mentioned in patients with mPCa are age above 70 years, cT4 stage or high-grade disease, PSA і 20 ng/ml, and pelvic lymphadenopathies. While comparing patients who underwent local treatment with those one who did not, the presence of these 3 or more CSS and OS factors conditions remains the same. Metastasis degree and location number can also influence outcome. Furthermore, visceral metastases lead to worse prognosis. Exploring new treatment options for mPCa awoke interest in scientists in recent years. Radical prostatectomy and target radiation therapy remain the most effective in achieving local disease control and, thus, control of systemic disease. There is growing evidence supporting local treatment in cases of metastatic prostate cancer at diagnosis in the context of a multimodal approach. However, its oncological effect requires prospective studies with well-defined patient selection criteria. Prospective multicentric studies might sustain the existing data and define the main indications for primary treatment in mPCa.

29 March 2024 in Health of Man
Verified
Journal Article
Open access
PDF file
SGSergii Golovko
Sergii Golovko
Bladder cancer (BC) is a 9th most common cancer in the world that make from 3% of global neoplasms. Bladder cancer is prevalent in the developed countries. Cancer of the bladder is four times more common in men than women. External risk factors and internal triggers contribute to the development of bladder cancer. Thus, comprehensive analysis of these risk factors is a earnest to timely prevention of indicated oncologic pathology. The objective: to do a current systematic review of epidemiology of bladder cancer and modern important risk factors, which appropriate to the given pathology. Evidence acquisition. We carried out a systemic review of epidemiology of bladder cancer embracing PubMed and Embase including March 2023. All studies reporting gender, smoking, E-cigarette use, opium consumption, occupational carcinogene expose, dietary factors, race, gene-environment interaction, socioeconomic status. Microbiome factors, urolithiasis, benign prostate hyperplasiapelvic radiotherapy were excluded. Evidence synthesis. A total of 516 papers, that studied epidemiology of bladder cancer, were involved. According to GLOBOCAN, there were 573 000 new bladder cancer cases and 213 000 deaths worldwide in 2020. Smoking and occupational exposures (aromatic amines and polycyclic aromatic hydrocarbons) are the most important risk factors. Moreover, the additional risk factors include some dietary agents, gene specificities, diesel exhaust emissions and etc. Conclusions. Smoking tobacco and specific occupational exposures are the most important risk factors. Prevention strategies, including smoke cessation, responsible workplace safety, diet, schistosomias prevention are useful for reduction of the incidence BC. But high-quality studies are required to confirm initial results that will support timely prevention of BC.

5 July 2022 in Urologiya
Verified
Journal Article
Open access
PDF file
SGS.V. Golovko
S.V. Golovko
AKA.A. Kobirnichenko
A.A. Kobirnichenko
VBV.R. Balabanyk
V.R. Balabanyk
VKV.M. Kravchuk
V.M. Kravchuk
Topicality. Kidney stone disease is referred to wide spread diseases. According to the literature data its prevalence is 732,8 cases per 100 000 of Ukrainian population. During the last years the usage of minimally invasive techniques, such as: extracorporeal shock-wave lithotripsy (ESWL) and ureteroscopy with contact lithotripsy has significantly increased, but percutaneous lithotripsy (PNL) remains as a technique of choice among basic methods of treatment of large size kidney stones. The purpose of the work. To evaluate the effectiveness of the percutaneous shock wave lithotripsy (PNL) in treatment of kidney stones larger than 50 mm. Materials and methods. Twenty-eight patients, among them twenty-five (89,28%) male patients and three (10,71%) female patients, with large > 50 mm kidney stones treated in NMMCC from April 2016 to March 2020 were included to the research. Stone-free rate and complications rates were examined. Results. In thirteen cases (46.42%) the stones were located in the right kidney, in fifteen cases (53,57%) the stones were located in the left kidney. The nineteen patients (67,85%) did not have any residual stones, and nine patients (32,14%) had residual stones. The extracorporeal shock-wave lithotripsy had been performed in 4 patients (14%), in 5 (17%) cases – contact lithotripsy of residual stones, which migrated to the lower third part of the ureter. After repeated intervention in 5 cases (17,86%) stone-free status was obtained. Stone-free rate index was 85,71%. Average duration of operation was 115±24,64 min. Hemoglobin level before and after operative intervention was 142 (117–159) g/l and 119 (94–132) g/l respectively (р 4 mm were considered as insignificant and significant respectfully. Conclusions. Percutaneous nephrolitotripsy is an effective and reliable method of treatment and should be a method of choice in treatment of staghorn stones and large size stones of the kidneys.

27 February 2019 in Klinicheskaia khirurgiia
Verified
Journal Article
Open access
PDF file
RSR. V. Savchuk
R. V. Savchuk
FKF. I. Kostyev
F. I. Kostyev
NMN. I. Molchanyuk
N. I. Molchanyuk
YDYu. M. Dekhtiar
Yu. M. Dekhtiar
SGS. V. Golovko
S. V. Golovko
Мета. Оцінити в експерименті ультраструктурні зміни слизової оболонки ортотопічного сечового міхура (СМ) карликових свиней через 12 міс після виконання ілеоцистопластики. Матеріали і методи. Експериментальні дослідження проведені на 18 самицях карликових свиней віком 4 – 15 міс, яким виконали цистектомію із формуванням ортотопічного СМ з клубової кишки. Результати. В ультраструктурі слизової оболонки штучно створеного СМ під тривалим впливом сечі стовпчасті клітини в епітеліальному шарі поступово заміщалися клітинами іншого типу, за структурою близькими до епітелію СМ, для виконання його повноцінної функції. Власна пластинка слизової оболонки мала явища деструктивного характеру переважно клітинних елементів, на окремих ділянках волокнисті структури переважали над клітинними. Висновки. Ультраструктурні зміни слизової оболонки штучно створеного СМ через 12 міс після ілеоцистопластики свідчать про її повну трансформацію і адаптацію з елементами еволюції та пристосування до нових умов життєдіяльності.

29 October 2018 in Klinicheskaia khirurgiia
Verified
Journal Article
Open access
PDF file
SGS. V. Golovko
S. V. Golovko
OSO. F. Savitsky
O. F. Savitsky
AKA. A. Kobirnichenko
A. A. Kobirnichenko
ALA. V. Lysak
A. V. Lysak
ITI. L. Troitskiy
I. L. Troitskiy
Мета. Покращити результати хірургічної реабілітації хворих з доброякісною гіперплазією передміхурової залози (ДГПЗ) та високим операційним ризиком, обгрунтувавши диференційований підхід до застосування селективної артеріальної емболізації (САЕ) та монополярної трансуретральної резекції передміхурової залози (ТУРПЗ). Матеріали і методи. Досліджено шляхом аналізу ефективність та безпечність САЕ передміхурової залози (ПЗ) як методу лікування симптомів нижніх сечовивідних шляхів (СНСШ) у хворих з ДГПЗ та високим операційним ризиком у порівнянні з ТУРПЗ. Аналіз базувався на систематичному вивченні функціональних результатів та ускладнень у 33 хворих основної групи, яким виконали САЕ, та у 39 хворих порівняльної групи, яким виконали ТУРПЗ. Результати. Хворі, яким виконали САЕ, не мали операційної травми, у них був низький ризик виникнення післяопераційних ускладнень, коротший післяопераційний період, покращились показники: Міжнародної шкали оцінки простатичних симптомів (IPSS) - на 47,8%, шкали оцінки якості життя (QoL) - на 53,3%, максимальної об’ємної швидкості струменя сечі (Qmax) - на 58,4% на фоні зменшення об’єму ПЗ на 28,6% та об’єму залишкової сечі на 55,3% протягом 24 міс спостереження, що є підставою вважати САЕ ПЗ ефективним та безпечним методом мініінвазивного лікування ДГПЗ у хворих з високим операційним ризиком. Після монополярної ТУРПЗ результати були подібні: покращення показників IPSS - на 50%, QoL - на 65,1%, Qmax - на 59,2%, зменшення об’єму ПЗ - на 31,6% та об’єму залишкової сечі - на 64,6%, але даний метод супроводжувався статистично більшою частотою післяопераційних ускладнень, що погіршувало рівень періопераційної безпеки. Висновки. Результати дослідження засвідчили, що САЕ є ефективним та безпечним методом лікування хворих з ДГПЗ та високим операційним ризиком, за результативністю порівнянним з ТУРПЗ, але з меншим ризиком виникнення післяопераційних ускладнень. САЕ може бути методом вибору у хворих похилого віку з вираженою супутньою патологією, які мають протипоказання до стандартного оперативного втручання або утримуються від нього з інших причин.